bioAffinity Technologies, Inc. Other Nonoperating Income
bioAffinity Technologies, Inc. (BIAF) reported Other Nonoperating Income of $4.74 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncome · last filed 2026-08-07
- bioAffinity Technologies, Inc. other nonoperating income for the quarter ending 2026-06-30 was $4.74K, a 87.55% decline year-over-year.
- bioAffinity Technologies, Inc. other nonoperating income for the quarter ending 2025-12-31 was $1.92K, a 200.31% increase year-over-year.
- bioAffinity Technologies, Inc. other nonoperating income for the quarter ending 2025-09-30 was $513.00, a 94.70% decline year-over-year.
- bioAffinity Technologies, Inc. other nonoperating income for the quarter ending 2025-06-30 was $38.05K, a 3805200.00% increase year-over-year.
- bioAffinity Technologies, Inc. other nonoperating income for fiscal 2025 was $40.49K, a 292.23% increase from fiscal 2024.
- bioAffinity Technologies, Inc. other nonoperating income for fiscal 2024 was $10.32K, a 210.47% increase from fiscal 2023.
- bioAffinity Technologies, Inc. other nonoperating income for fiscal 2023 was $3.33K.
| Period end | Other Nonoperating Income 3 month | Other Nonoperating Income 6 month | Other Nonoperating Income 9 month | Other Nonoperating Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.74K 10-Q · filed 2026-08-07 | $3.37K 10-Q · filed 2026-08-07 | ||
| 2025-12-31 | $1.92K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.44K derived: sum of 2 quarters · filed 2026-03-16 | $40.49K derived: sum of 3 quarters · filed 2026-08-07 | $40.49K 10-K · filed 2026-03-16 |
| 2025-09-30 | $513.00 10-Q · filed 2025-11-14 | $38.57K derived: sum of 2 quarters · filed 2026-08-07 | $38.57K 10-Q · filed 2025-11-14 | $39.21K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $38.05K 10-Q · filed 2026-08-07 | $38.05K 10-Q · filed 2026-08-07 | $38.70K derived: sum of 3 quarters · filed 2026-08-07 | $48.38K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.00 10-Q · filed 2026-05-11 | $642.00 derived: sum of 2 quarters · filed 2026-05-11 | $10.32K derived: sum of 3 quarters · filed 2026-05-11 | $10.33K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $640.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $10.32K derived: sum of 2 quarters · filed 2026-03-16 | $10.32K derived: sum of 3 quarters · filed 2026-03-16 | $10.32K 10-K · filed 2026-03-16 |
| 2024-09-30 | $9.68K 10-Q · filed 2025-11-14 | $9.68K derived: sum of 2 quarters · filed 2025-11-14 | $9.68K 10-Q · filed 2025-11-14 | $12.91K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.00 10-Q · filed 2025-08-14 | $4.51K 10-Q · filed 2025-08-14 | $3.23K derived: sum of 3 quarters · filed 2025-08-14 | $7.84K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $4.51K 10-Q · filed 2025-05-15 | $3.23K derived: sum of 2 quarters · filed 2025-05-15 | $7.83K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$1.28K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.33K derived: sum of 2 quarters · filed 2025-03-31 | $3.33K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $4.61K 10-Q · filed 2024-11-14 | $4.61K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |